Preprocedural high-sensitive troponin predicts survival after transcatheter aortic valve implantation (TAVI).
Department of Cardiology and Angiology, UKSH, University of Kiel, Germany. Electronic address: derk.frank@uksh.de.
Derk
D
Frank
Sophia
S
Stark
Matthias
M
Lutz
Anne
A
Weissbrodt
Sandra
S
Freitag-Wolf
Rainer
R
Petzina
Mark
M
Rosenberg
Georg
G
Lutter
Norbert
N
Frey
D000368:Aged; D000369:Aged, 80 and over; D001024:Aortic Valve Stenosis / Q000097:blood* / Q000401:mortality* / Q000601:surgery; D015415:Biomarkers / Q000097:blood; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000401:mortality*; D005260:Female; D005500:Follow-Up Studies; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000401:mortality*; D006801:Humans; D008297:Male; D011237:Predictive Value of Tests; D011300:Preoperative Care / Q000379:methods / Q000401:mortality*; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D015996:Survival Rate / Q000639:trends; D014336:Troponin / Q000097:blood*
D015415:Biomarkers; D014336:Troponin
AR; Aortic stenosis; Biomarkers; C-reactive protein; CRP; LBBB; N-terminal b-type natriuretic peptide; NTproBNP; Prognosis; TA; TAVI; TAVI/TAVR; TF; Transcatheter aortic valve implantation/replacement; aortic regurgitation; high sensitive troponin T; hsTnT; left bundle branch block; transapical access; transfemoral access